Chinese Academy of Medical Sciences – Gastric Cancer.

Access Program Information

– To determine the maximum-tolerated dose (MTD) and dose-limiting toxicity (DLT) of
sorafenib in combination with FOLFOX4 (oxaliplatin/leucovorin/5-fluorouracil) as
first-line treatment for advanced gastric cancer

– The design of the study incorporated a standard 3 + 3 dose escalation procedure to
guide elevation of the sorafenib dosage to the next level

Rare Disease: